Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.
Send us all your questions or requests, and our expert team will assist you.
While it is true that we cannot yet “edit” the DNA in a living person to fix a genetic error, this does not mean there is no treatment for nephrogenetic conditions. On the contrary, the management of these diseases is active, effective, and constantly improving. The goal of treatment is to protect the kidneys, slow down the progression of damage, and manage the symptoms to ensure the highest possible quality of life. Knowing the specific genetic cause allows doctors to tailor the treatment plan precisely, avoiding drugs that don’t work and focusing on therapies that target the specific biological pathway involved. Follow-up is a lifelong partnership, ensuring that as the patient’s life changes, their care adapts.
Much of the daily treatment for genetic kidney disease focuses on symptom management. Pain is a significant issue for patients with structural diseases like Polycystic Kidney Disease (PKD). As cysts grow, they can cause a dull ache or sharp pain if they rupture.
Doctors typically recommend a stepwise approach to pain.
We are entering a new era of “precision medicine” in nephrology. For certain genetic conditions, there are now drugs available that target the underlying mechanism of the disease. The most prominent example is Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Tolvaptan works by blocking a hormone called vasopressin. In people with PKD, vasopressin stimulates the cysts to grow. By blocking it, the drug slows down the growth of the cysts and preserves kidney function for longer. While it may not be a cure, it can provide patients with additional years of health before the need for dialysis arises. This drug requires careful monitoring because it causes extreme thirst and frequent urination, but it represents a major leap forward. Research is ongoing for similar targeted drugs for Alport syndrome and other genetic conditions.
Controlling blood pressure is arguably the most critical intervention for any genetic kidney disease. High blood pressure is both a symptom of kidney distress and a cause of further damage. It pounds the delicate filters of the kidney, causing scarring.
For genetic patients, doctors usually prescribe a specific class of blood pressure medications called ACE inhibitors or ARBs (drugs ending in -pril or -sartan). These drugs are unique in that they not only lower blood pressure throughout the body but also specifically relax the blood vessels inside the kidney. This procedure reduces the internal pressure on the filters, protecting them from wear and tear. The goal is to keep blood pressure strictly controlled, often lower than the standard target for the general population, to provide maximum protection for the organs.
For many patients with severe genetic kidney disease, there may come a time when the kidneys can no longer keep up with the body’s needs. This is called End-Stage Renal Disease (ESRD). At this point, renal replacement therapy is needed.
Kidney transplantation is often considered the best treatment option for genetic kidney disease. For genetic patients, there is a distinct advantage: the disease generally does not recur in the new kidney. Since the new kidney has different DNA (from the donor), it does not have the genetic instructions to form cysts or have weak filters. This means a transplant can effectively “cure” the kidney failure component of the disease.
Dialysis is the alternative if a transplant is not immediately available. It involves using a machine to filter the blood. It is a life-sustaining treatment that can be done at a clinic or at home.
Nephrogenetics requires long-term vigilance. Patients typically see their nephrologist every 6 to 12 months, or more frequently if their function is changing. During these visits, the doctor monitors key numbers:
By tracking these trends, doctors can intervene early. If blood pressure starts to creep up, they can adjust medications immediately. If anemia develops, they can treat it. This proactive monitoring prevents small problems from becoming emergencies.
Treating a genetic disease often requires a village. A patient’s care team usually includes several specialists working together.
Liv Hospital Vadistanbul
Prof. MD. Süleyman Tevfik Ecder
Nephrology
Liv Hospital Bahçeşehir
Asst. Prof. MD. Himmet Bora Uslu
Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Mehmet Taşdemir
Pediatric Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Ozan Özkaya
Pediatric Nephrology
Liv Hospital Ankara
Asst. Prof. MD. Feyza Bayrakdar Çağlayan
Nephrology
Liv Hospital Ankara
Prof. MD. Hüsnü Oğuz Söylemezoğlu
Pediatric Nephrology
Liv Bona Dea Hospital Bakü
MD. FERHAD ŞİRİNOV
Nephrology
Send us all your questions or requests, and our expert team will assist you.
You can only donate if you do not have the genetic disease yourself.
No. It is specifically approved for adults with ADPKD who are at risk of rapidly progressing disease. It has specific side effects and requirements that your doctor will evaluate.
Not necessarily. Many people with genetic kidney disease have mild forms and live their whole lives without kidney failure. It depends on your specific mutation and how well you manage your blood pressure.
Be cautious. Many herbal supplements can be toxic to the kidneys or interact with your medications. Always show your list of supplements to your nephrologist before taking them.
For PKD specifically, staying very well hydrated is often recommended because it naturally suppresses the hormone that drives cyst growth. Ask your doctor for a specific daily water goal.
BlogNephrogeneticsApr 14, 2026Understand the distinct functions and locations of cortical vs. juxtamedullary nephrons, the key components...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 42 01